ERBB2 and breast carcinoma: Other chemotherapeutic agents used in the therapy against brain metastasis in breast cancer, that express activity anti-HER-2, are trastuzumab [148], lapatinib [149], neratinib [150], afatinib [151], pertuzumab [152], and sagopilone [153].